Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey
Background: There is limited knowledge of physicians’ antiarrhythmic drug (AAD) treatment practices for patients with atrial fibrillation and adherence to guidelines in European countries. Methods: An online survey (n = 321) of cardiologists, cardiac electrophysiologists and interventional electroph...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-08-01
|
| Ráidu: | International Journal of Cardiology: Heart & Vasculature |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2352906725001125 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|